In the early days of atrial‑fibrillation ablation, surgeons had to puncture the heart’s wall by feel alone, a risky blind‑folded process that could cause fatal complications. The arrival of three‑dimensional mapping systems turned the procedure into a visual, repeatable operation and opened the door for nationwide adoption. Today, Chinese experts are debating the next step for domestic cardiovascular devices. On one side, clinicians argue that rigid, foreign‑made standards strip doctors of the nuanced “feel” built from thousands of surgeries, forcing them to follow preset parameters like a GPS. On the other, innovators contend that standardized, visual‑guided tools are essential for patient safety and for training doctors across the country. Chinese companies are answering the call. New implantable cardioverter‑defibrillators (ICDs) and pulsed‑field ablation (PFA) catheters claim to cut mis‑fires and target lesions more precisely. Breakthroughs such as a trans‑catheter tricuspid‑valve repair clip and biodegradable septal‑defect occluders promise minimally invasive fixes without permanent metal implants. The consensus emerging from a recent “Doctor‑Enterprise Face‑to‑Face” conference is that innovation must blend clear visualization, solid standards, and the seasoned intuition of Chinese physicians. Only then can home‑grown heart devices truly protect patients and compete with overseas giants.
Read more